Drug Trial Radar · NCT00095758
A Study of Adjunctive Aripiprazole in Participants With Major Depressive Disorder
Last checked: Nov 20, 2026Latest source record: Jul 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,151
Actual
Start
Sep 1, 2004
Primary completion
Dec 1, 2006
Study completion Dec 1, 2006
Sponsor
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.Otsuka
- Sponsor type
- Industry
- Collaborators
- Otsuka America Pharmaceutical
- First posted
- Nov 9, 2004
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial is a 14 week, randomized, double-blind, placebo controlled study, to assess the safety and efficacy of aripiprazole as adjunctive treatment to an ongoing antidepressant treatment in patients with Major Depressive Disorder.
Conditions
- Major Depressive Disorder
Interventions
Antidepressant + PlaceboDrug
Antidepressant Caps/Tablets Placebo Tablets, Oral, 2-20 mg Placebo, once daily, 6 weeks following an 8 week Prospective Treatment (Baseline) Phase.
Antidepressant + AripiprazoleDrug
Antidepressant Caps/Tablets Aripiprazole Tablets, Oral, 2-20 mg Aripiprazole, once daily, 6 weeks following an 8 week Prospective Treatment (Baseline) Phase.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in a depression rating scale at endpointTime frame: Baseline, Week 8
Locations
28 sites in 1 country. Site status is shown where the registry gives one.
Local Institution
Beverly Hills, California
Local Institution
Burbank, California
Local Institution
National City, California
Local Institution
Orange, California
Local Institution
Pasadena, California
Local Institution
Denver, Colorado
Local Institution
Farmington, Connecticut
Local Institution
Jacksonville, Florida
Local Institution
Orlando, Florida
Local Institution
Atlanta, Georgia
Local Institution
Rockville, Maryland
Local Institution
Albuquerque, New Mexico
Local Institution
Brooklyn, New York
Local Institution
New York, New York
Local Institution
Cincinnati, Ohio
Local Institution
Toledo, Ohio
Local Institution
Portland, Oregon
Local Institution
Pittsburgh, Pennsylvania
Local Institution
Memphis, Tennessee
Local Institution
Dallas, Texas
Local Institution
Houston, Texas
Local Institution
Arlington, Virginia
Local Institution
Herndon, Virginia
Local Institution
Richmond, Virginia
Local Institution
Bellevue, Washington
Local Institution
Seattle, Washington
Local Institution
Brown Deer, Wisconsin
Local Institution
Middleton, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.